Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report

World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report

  • Authors:
    • Li Gong
    • Lu Sun
    • Chenling Zhang
    • Sanhua Wei
    • Jun Chen
    • Yazhuo Li
    • Yanhong Li
    • Wei Zhang
    • Yongsheng Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Department of Pathology, Hainan Branch of General Hospital of the Chinese People's Liberation Army, Sanya, Hainan 572013, P.R. China, Department of Gynaecology and Obstetrics, Baoji Central Hospital, Baoji, Shaanxi 721008, P.R. China, Department of Clinical Laboratory, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Department of Orthopedics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Research Service Office, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China
  • Pages: 9283-9286
    |
    Published online on: April 11, 2018
       https://doi.org/10.3892/ol.2018.8459
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Hassall's corpuscles (HCs) are characteristic components of the medulla of the mammalian thymus and thymoma with an abundance of HCs is even more rare, with only five cases having been reported in the literature, to the best of our knowledge. Furthermore, their morphology usually resembles World Health Organization (WHO) type B2 or B3 thymoma. The biological behavior appears indolent and is rarely associated with myasthenia gravis. However, whether it is a separate entity or a variant of organotypical thymoma WHO B2 or B3 remains to be elucidated. The present case report reports a type B2 thymoma with a large presence of HCs from a 58‑year‑old Chinese woman, and investigates its histopathological characteristics, immunological features and biological behavior. Notably, the present case appeared biologically more aggressive compared with the cases reported previously. The aim of describing this rare case of thymoma with an abundance of HCs is so that it can be recognized and classified by pathologists.

Introduction

Hassall's corpuscles (HCs) are characteristic structures of the normal thymus and are commonly used as diagnostic features for identifying the human thymus (1). The majority of studies consider that they are derived from epithelial cells of the thymic medulla (2–4). Typical HCs are occasionally identified in areas with medullary differentiation of World Health Organization (WHO) type B1-3 thymoma; however, they are not identified in type A and AB thymoma (5–11). Thymoma with an abundance of HCs is rare, with only five cases having been reported in the literature (12), to the best of our knowledge. The present case report concerns a type B2 thymoma with an abundance of HCs in a 58-year-old Chinese woman and considers its clinicopathological characteristics, immunological phenotype and biological behavior. The aim of describing this rare type of thymoma is so that it can be recognized and classified by pathologists. In addition, it is advised that clinical doctors should follow-up these patients due to its undefined biological behavior.

Case report

A 58-year-old Chinese woman was admitted to the Hainan Branch of General Hospital of the Chinese People's Liberation Army (Hainan, China) on 19 April 2015 due to a repeated pain in the right anterior chest for 6 months. The pain was often exacerbated when the body posture was changed and was accompanied simultaneously by malaise, without eyelid ptosis, cough, headache, shortness of breath or dizziness. A computed tomography (CT) scan of the chest revealed a heterogeneous mass, with a size of 8.2×6.2×4.6 cm in the right anterior superior mediastinum, involving the right pericardium and wrapping around the superior and inferior vena cava (Fig. 1). Thus, an exploratory thoracotomy was performed. However, it was not possible to resect the tumor completely as it was difficult to separate it from the superior and inferior vena cava. Grossly, the tumor adhered to the down lobe of the right lung, the size was 7.5×7.5×5 cm, the encapsulation was not intact, the cut surface was yellow-grey and the texture was of a medium hardness. The resected samples were fixed in 10% neutral formalin solution, and embedded in paraffin. Serial sections were stained with hematoxylin and eosin (H&E). Microscopically, a large quantity of HCs with various morphologies, including solid, cystic, round and irregular, were initially identified to be diffusely distributed. The size of the HCs varied from extremely small to large. Large and polygonal neoplastic epithelial cells were scattered individually or in small clusters among immature lymphocytes, and formed a delicate loose network. Their nucleoli were prominent. Only a limited number of the tumor cells were arranged in the small papillary or nested histoarchitecture in the focal area. Certain tumor cells were involved in the lung tissues and adipose tissue out of the pleura. Furthermore, the HCs in the tumor involved in the lung tissues appeared to be small, and there were no cystic structures. Cystic spaces filled with fibrin, blood or HCs, cholesterol crystal, scarring, necrosis and calcium deposits were identified (Fig. 2). Immunohistochemically, Sections (4-µm thick) from a representative block were deparaffinized in 99% xylene for 15 min at room temperature, rehydrated in graded alcohol (ethanol) with 100, 95, 80 and 75% in turn, incubated with 3% H2O2 to block the activity of endogenous peroxidases for 10 min at room temperature. The sections were then subjected to heat-induced antigen retrieval in 0.1 mol/l citrate buffer at pH 6.0 for 3 min following treatment with EDTA buffer at pH 9.0 in a microwave for 15 min. The slides were then incubated with ready-to-use mouse anti-human primary monoclonal antibody against pan-cytokeratin (CK; MAB-0671), CK19 (kit-0020), cluster of differentiation (CD)99 (MAB-0059), CD20 (MAB-0669), and CD1a (MAB-0336), rabbit anti-human monoclonal antibodies against epithelial membrane antigen (EMA) (kit-0011), CD5 (MAB-0252), and CD117 (MAB-0590) for 1 h at 37°C. After excess primary antibody was removed with PBS buffer solution, the ready-to-use goat anti-mouse/rabbit IgG polymer conjugated with horseradish peroxidase (kit-0016) were applied and incubated for 20 min at room temperature. Then, a subsequent reaction was performed and visualized using 40 µl 3.3′-diaminobenzidine (DAB) buffer with fresh configuration (concentration, 0.2 g/20 ml PBS) for 5–8 min at room temperature. Finally, the slides were incubated with hematoxylin staining solution for 20 sec, and washed using water. All of these reagents were provided by Maxim Biotech, Develop Co. (Fuzhou, Fujian, China). After mounting, the slides were observed by a light microscope (DM2500, Leica Microsystems Wetzlar GmbH). The results demonstrated that the tumor cells were positive for pan-CK and CK19, and negative for EMA and CD5, CD117 and CD20 (Fig. 3). Intraepithelial lymphocytes were positive for CD1a, CD5 and CD99. The index of Ki-67 was high (~80%). Therefore, type B2 thymoma with an abundance of HCs was eventually diagnosed. However, she did not undergo further therapy and was discharged from the hospital for financial reasons. Therefore, the patient was not followed-up until she revisited due to pain in the right anterior chest 9 months after surgery. Unfortunately, the patient was unwilling to undergo an imaging examination again.

Figure 1.

(A) Conventional and (B) enhanced computer tomography scans of the patient's chest revealed a heterogeneous mass of 8.2×6.2×4.6 cm in the right anterior superior mediastinum. (C) Coronal and (D) sagittal views showed the mass involved the right pericardium and wrapping around the superior and inferior vena cava.

Figure 2.

Microscopically, large HCs with various shapes, including solid, cystic, round and irregular HCs, were found to diffusely distribute. The size of HCs varied from (A) very small (magnification, ×200) to (B) very large (magnification, ×100). (C, magnification, ×400) Large and polygonal neoplastic epithelial cells scattered individually or in small clusters among immature lymphocytes, and (D, magnification, ×400) formed a delicate loose network with prominent nucleoli. (E) Only a limited number of tumor cells were arranged in small papillary or nested histoarchitecture in focal area (magnification, ×200). (F) Certain tumor cells were involved in the lung tissues (magnification, ×100). Cystic spaces filled with (G) fibrin, blood or HCs (magnification, ×100). (H) Cholesterol crystal, scarring, necrosis and calcium deposits were identified (magnification, ×100).

Figure 3.

Immunohistochemistry. The tumor cells demonstrated positive expression of (A) CK19 (magnification, ×100) and (B) pan CK (magnification, ×100) and negative for (C) epithelial membrane antigen (magnification, ×100). Intraepithelial lymphocytes demonstrated positive expression of (D) CD1a (magnification, ×200), (E) CD5 (magnification, ×200) and (F) CD99 (magnification, ×200).

Discussion

HCs, which are characteristic structures of the human thymus, are derived from epithelial cells of the thymic medulla (2–4). The physical nature of these structures differs between mammalian species, for example, they are abundant in the human thymus, but relatively rare in the mouse thymus (13). It has been suggested previously that HCs serve a function in the removal of apoptotic thymocytes and the maturation of developing thymocytes within the thymus (14). However, the function remains to be elucidated. Typical HCs are occasionally identified in areas with medullary differentiation of WHO type B1-3 thymoma; however, they have not been identified in type A and AB thymoma (5–11). Thymoma with an abundance of HCs is rare, and has been termed ‘corpuscular thymoma’ by Laeng et al (12). To the best of our knowledge, only five cases have been reported previously (12). Clinically, the occurrence of the majority of thymoma are latent and not easily observed. Only one case demonstrated the symptom of eyelid ptosis. The other four cases were asymptomatic and were incidentally identified. Simultaneously, no association with myasthenia gravis or other autoimmune diseases was observed. The patient in the present study exhibited none of the aforementioned symptoms or diseases, with the exception of a repeated pain in the right anterior chest. The age range of the known cases was between 41 and 86 years, including the present case, and the average age was 64 years when the diagnosis was performed. The cases reported were of three men and three women, suggesting that sex is not a factor.

Histopathologically, the morphology varied, although they resembled type B2 or B3 thymoma (12). In the present case, the majority of the epithelial cells formed a loose network and only a limited number of tumor cells were arranged in a small papillary or nested histoarchitecture in the focal area. The HCs were polymorphic, including solid, cystic, round, and irregular shapes. The size of HCs varied from extremely small to large. Cystic spaces, which were filled with fibrin, blood or HCs, were also observed. Immunohistochemically, the tumor cells were positive for CK19 and pan-CK with reticular formation, and negative for EMA, CD5, CD117 and CD20. These characteristics differed from those of type B3 thymoma or squamous cell carcinoma. In addition, intraepithelial lymphocytes were positive for CD1a, CD5 and CD99, and immature T cells were identified. The above histopathological characteristics and immunohistochemical features supported the diagnosis of type B2 thymoma. However, of note are the numerous HCs with polymorphism and different sizes in thymoma, which instigated the observation of various HCs. Only five cases, including three of type B2 and two of type B3, have been described in the literature (12), to the best of our knowledge. Furthermore, these previous studies had the same aim as that of the present case report, and investigated whether this rare observation maybe a distinct entity or variant of organotypical thymoma WHO B2/B3, and also investigated the missing association between thymoma with an abundance of HCs and thymic carcinoma. However, the results demonstrated that the prevalence of HCs did not herald the association between type B2/B3 thymoma and thymic carcinoma. Finally, the previous studies considered that the corpuscular differentiation was an option for neoplastic cells in organotypical thymoma and may give rise to the predominant histoarchitectural pattern, resulting in a rare distinct variant (12). This was also concluded in the present case. In addition, a previous study demonstrated numerous and large HCs, with highly polymorphic shapes, were identified in human fetuses, and these increased rapidly in number and size at ~28 weeks of gestation, prior to subsequently increasing at a decreased rate (1). It was speculated that these HCs changes were also associated with the negative selection process of thymocytes (1). It remains to be elucidated whether a large quantity of HCs in the thymoma may assist with removing apoptotic self-reacting thymocytes. However, the study by Laeng et al (12) detected the apoptotic cells in five cases of thymoma and the results demonstrated that apoptotic cells were prominent in areas of regressive change in all cases. Additionally, the labeling indices of apoptotic cells outnumbered those for proliferating neoplastic cells (12). However, further studies are required to elucidate this molecular mechanism.

Regarding biological behavior, the five cases reported in the literature appeared indolent. By contrast, the tumor in the present study was involved in the lung tissues and right pericardium, although a number of distinctions, including cholesterol crystal, scarring, necrosis and calcium deposits, suggested that it was a long-standing lesion. Furthermore, the tumor wrapped around the superior and inferior vena cava. Thus, the biological behavior of the type of thymoma remains undefined.

Patients such as these should be followed-up regularly. The patient in the present case report began having a severe pain in the right anterior chest 9 months after surgery. It was predicted that the tumor may recur for two reasons. One was that the tumor was invasive, and the other was that the tumor tissue adhering to the pericardium was not resected completely. However, recurrence could not be confirmed as the individual did not agree to undergo an imaging examination.

In conclusion, the type B2 or B3 thymoma abundance of HCs is rare. Further elucidation is required as to whether it represents a variant of WHO type B2 or B3 thymoma or whether it qualifies as a distinct entity. In addition, it should be differentiated from thymic hyperplasia.

Glossary

Abbreviations

Abbreviations:

CK

cytokeratin

CT

computed tomography

EMA

epithelial membrane antigen

HCs

Hassall's corpuscles

References

1 

Asghar A, Syed YM and Nafis FA: Polymorphism of Hassall's corpuscles in thymus of human fetuses. Int J Appl Basic Med Res. 2:7–10. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Laster AJ, Itoh T, Palker TJ and Haynes BF: The human thymic microenvironment: Thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation. Differentiation. 31:67–77. 1986. View Article : Google Scholar : PubMed/NCBI

3 

Nicolas JF, Reano A, Kaiserlian D and Thivolet J: Epithelial cell heterogeneity in mammalian thymus: Monoclonal antibody to high molecular weight keratins exclusively binds to Hassall's corpuscles. Histochem J. 21:357–364. 1989. View Article : Google Scholar : PubMed/NCBI

4 

Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, Bean AG, Ladyman HM, Ritter MA and Hugo P: The thymic microenvironment. Immunol Today. 14:445–459. 1993. View Article : Google Scholar : PubMed/NCBI

5 

Kuo TT, Mukai K, Eimoto T, Laeng RH, Henry K and Chan JKC: Type A thymomaTravis WD, Brambilla E, Müller-Hermelink HK and Harris CC: Tumours of the Lungs, Pleura and Mediastinum. World Health Organisation Classification of Tumours, IARC Press; Lyon, France: pp. 154–158. 2004

6 

Marino M and Müller-Hermelink HK: Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch. 407:119–149. 1985. View Article : Google Scholar

7 

Marx A and Müller-Hermelink HK: From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. Pathol Res Pract. 195:515–533. 1999. View Article : Google Scholar : PubMed/NCBI

8 

Müller-Hermelink HK, Marx A and Kirchner T: Advances in the diagnosis and classification of thymic epithelial tumoursAnthony PP and MacSween RNM: Recent Advances in Histopathology. Churchill Livingstone, Edinburgh: pp. 49–72. 1994

9 

Pan CC, Chen WY and Chiang H: Spindle cell and mixed spindle/lymphocytic thymomas. An integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Path. 25:111–120. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E and Harris NL: Thymoma: Histologic subclassification is an independent prognostic factor. Cancer. 74:606–617. 1994. View Article : Google Scholar : PubMed/NCBI

11 

Shimosato Y and Mukai K: Tumors of the mediastinumRosai J and Sobin LH: Atlas of Tumor Pathology, Armed Forces Institute of Pathology. Washington DC: pp. 93–101. 1997

12 

Laeng RH, Eimoto T, Kuo TT, Zettl A, Marx A, Moschopulos M, Tateyama H and Shimokawa K: Corpuscularthymoma: Entity or variant of organotypicalthymomas WHO B2/B3? Pathol Res Pract. 202:697–704. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Farr AG, Dooley JL and Erickson M: Organization of thymic medullary epithelial heterogeneity: Implications for mechanisms of epithelial differentiation. Immunol Rev. 189:20–27. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W and Liu YJ: Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 436:1181–1185. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gong L, Sun L, Zhang C, Wei S, Chen J, Li Y, Li Y, Zhang W and Zhang Y: World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report. Oncol Lett 15: 9283-9286, 2018.
APA
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y. ... Zhang, Y. (2018). World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report. Oncology Letters, 15, 9283-9286. https://doi.org/10.3892/ol.2018.8459
MLA
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y., Li, Y., Zhang, W., Zhang, Y."World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report". Oncology Letters 15.6 (2018): 9283-9286.
Chicago
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y., Li, Y., Zhang, W., Zhang, Y."World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report". Oncology Letters 15, no. 6 (2018): 9283-9286. https://doi.org/10.3892/ol.2018.8459
Copy and paste a formatted citation
x
Spandidos Publications style
Gong L, Sun L, Zhang C, Wei S, Chen J, Li Y, Li Y, Zhang W and Zhang Y: World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report. Oncol Lett 15: 9283-9286, 2018.
APA
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y. ... Zhang, Y. (2018). World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report. Oncology Letters, 15, 9283-9286. https://doi.org/10.3892/ol.2018.8459
MLA
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y., Li, Y., Zhang, W., Zhang, Y."World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report". Oncology Letters 15.6 (2018): 9283-9286.
Chicago
Gong, L., Sun, L., Zhang, C., Wei, S., Chen, J., Li, Y., Li, Y., Zhang, W., Zhang, Y."World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report". Oncology Letters 15, no. 6 (2018): 9283-9286. https://doi.org/10.3892/ol.2018.8459
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team